Viewing Study NCT02128269

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:46 PM

Ignite Modification Date: 2026-01-02 @ 8:20 PM

Study NCT ID: NCT02128269

Status: TERMINATED

Last Update Posted: 2017-07-13

First Post: 2014-04-29

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome

Sponsor: Alexion Pharmaceuticals, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module